Bruker Corp - Current report filing (8-K)
March 17 2008 - 5:33AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 17,
2008
BRUKER CORPORATION
(Exact name of
registrant as specified in its charter)
Delaware
(State or other
jurisdiction
of incorporation)
|
|
000-30833
(Commission
File Number)
|
|
04-3110160
(IRS Employer
Identification No.)
|
40
Manning Road
Billerica, MA 01821
(Address of principal
executive offices)(Zip Code)
Registrants telephone number, including area code:
(978) 663-3660
Check
the appropriate box if the Form 8-K filing is intended to simultaneously
satisfy the reporting obligation of the registrant under any of the following
provisions:
|
|
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act
|
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 of the Exchange Act
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) Exchange Act
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) Exchange Act
|
Section 2
Financial Information
Item
2.02. Results of Operations and
Financial Condition
The information in this
Current Report on Form 8-K, including Exhibit 99.1 attached hereto,
is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, and shall not be incorporated by reference into any
filing of the company under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such filing.
On March 17, 2008,
Bruker Corporation issued a press release announcing combined financial results
as of and for the three and twelve months ended December 31, 2007,
including the results of the Bruker BioSpin Group acquired on February 26,
2008. A copy of the press release is
attached hereto as Exhibit 99.1.
2
Section 9
Financial Statements and Exhibits
Item
9.01. Financial Statements and Exhibits.
(d) Exhibits
Number
|
|
|
|
|
|
99.1
|
|
Press release dated
March 17, 2008.
|
3
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
|
BRUKER CORPORATION
|
|
(Registrant)
|
|
|
|
Date: March 17,
2008
|
By:
|
/s/Frank H. Laukien
|
|
|
Frank H. Laukien, Ph.D.
|
|
|
Chief
Executive Officer and President
|
4
Exhibit Index
Exhibit Number
|
|
Exhibit Name
|
|
Location
|
|
|
|
|
|
99.1
|
|
Press release dated
March 17, 2008.
|
|
Furnished herewith*
|
*
Exhibit 99.1 attached hereto is
being furnished and shall not be deemed filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section, nor shall such information be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended, except
as shall be expressly set forth by specific reference in such filing.
5
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024